Hiemstra P S, Daha M R, Bouma B N
Thromb Res. 1985 Jun 1;38(5):491-503. doi: 10.1016/0049-3848(85)90182-3.
The cleavage of factor B, a protein of the alternative pathway of complement, by kallikrein was studied. Like factor D, kallikrein can cleave B to generate the alternative pathway C3 convertase C3bBb. When this convertase was formed on erythrocytes previously coated with C3b, lysis was observed indicating that a functionally active C3 convertase was formed. B was also cleaved by kallikrein in the presence of fluid phase C3b, and this resulted in B fragments comparable in size to those generated in the presence of D. The capacity of kallikrein to cleave B is localised in the light chain of the kallikrein molecule, which is the same chain of kallikrein that is responsible for its other enzymatic activities. Since on a molar basis D is much more active then kallikrein in cleaving B, a physiological role for B activation by kallikrein is only likely under certain conditions, and still has to be established.
研究了激肽释放酶对补体替代途径蛋白B因子的裂解作用。与D因子一样,激肽释放酶可裂解B因子以生成替代途径C3转化酶C3bBb。当这种转化酶在先前包被有C3b的红细胞上形成时,可观察到细胞溶解,表明形成了功能活性C3转化酶。在液相C3b存在的情况下,激肽释放酶也可裂解B因子,这导致产生的B片段大小与在D因子存在时产生的片段相当。激肽释放酶裂解B因子的能力定位于激肽释放酶分子的轻链,该轻链也是激肽释放酶负责其其他酶活性的链。由于在摩尔基础上,D因子在裂解B因子方面比激肽释放酶活性高得多,因此激肽释放酶激活B因子的生理作用仅在某些条件下才可能存在,仍有待确定。